Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-13 Sale | 2024-02-15 5:43 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 2,832 | $133.02 | $376,700 | 649,655 (Direct) | View |
| 2024-02-13 Purchase | 2024-02-15 4:02 pm | Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director | 53 | $19.12 | $1,013 | 5,060 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 7:21 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 5,314 | $138.74 | $737,271 | 506,962 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:21 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 2,707 | $140.69 | $380,845 | 502,188 (Direct) | View |
| 2024-01-08 Sale | 2024-01-10 4:31 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 167,858 | $133.02 | $22,328,417 | 561,777 (Direct) | View |
| 2023-08-21 Sale | 2023-08-23 8:08 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 9,328 | $107.4 | $1,001,816 | 499,754 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:28 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 29,044 | $102.9 | $2,988,758 | 491,365 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 5:19 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 2,707 | $110.08 | $297,997 | 465,278 (Direct) | View |
| 2022-02-07 Sale | 2022-02-09 7:00 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 10,984 | $80.54 | $884,674 | 462,844 (Direct) | View |
| 2021-02-05 Sale | 2021-02-09 9:17 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 12,888 | $116.26 | $1,498,368 | 573,850 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 4:16 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 308,250 | $110.22 | $33,973,877 | 441,071 (Direct) | View |
| 2020-11-12 Sale | 2020-11-16 6:16 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 3,390 | $90.78 | $307,748 | 441,071 (Direct) | View |
| 2020-08-05 Sale | 2020-08-07 7:29 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 3,390 | $118.91 | $403,101 | 438,021 (Direct) | View |
| 2020-04-24 Sale | 2020-04-28 8:41 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 2,906 | $99.45 | $289,016 | 434,971 (Direct) | View |
| 2020-02-07 Sale | 2020-02-11 7:14 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 3,248 | $103.35 | $335,696 | 432,357 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 6:44 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 9,792 | $102.41 | $1,002,793 | 598,215 (Direct) | View |
| 2019-08-06 Sale | 2019-08-08 7:39 pm | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 80,000 | $95.31 | $7,624,975 | 903,363 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-15 5:43 pm | N/A 2034-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 135,059 | $0 | 649,655 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-14 5:17 pm | N/A 2026-02-05 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 2,778 | $35.99 | 512,052 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-14 5:17 pm | N/A 2027-02-06 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 2,312 | $43.24 | 512,052 (Direct) | View |
| 2024-01-08 Exercise | 2024-01-10 4:31 pm | N/A 2024-01-16 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 167,858 | $19.59 | 561,777 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-22 5:55 pm | N/A 2033-06-20 | Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director | 15,020 | $0 | 15,020 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:11 pm | N/A 2033-02-13 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 155,162 | $0 | 155,162 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:50 pm | N/A 2032-06-23 | Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director | 21,412 | $0 | 21,412 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:51 pm | N/A 2032-01-31 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 160,614 | $0 | 160,614 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 8:01 pm | N/A 2031-06-24 | Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director | 9,728 | $0 | 9,728 (Direct) | View |
| 2021-02-08 Option Award(A) | 2021-03-29 06:19 am | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 113,863 | $0 | 113,863 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-09 9:17 pm | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 120,878 | $0 | 573,850 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:16 pm | N/A 2023-01-10 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 164,801 | $8.65 | 441,071 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-12 4:16 pm | N/A 2022-01-12 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 143,449 | $8.66 | 441,071 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 8:24 pm | N/A 2030-06-24 | Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director | 13,953 | $0 | 13,953 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 6:44 pm | N/A 2030-02-06 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 168,779 | $0 | 598,215 (Direct) | View |
| 2019-08-09 Exercise | 2019-08-13 4:44 pm | N/A 2025-02-03 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 3,031 | $32.99 | 420,628 (Direct) | View |
| 2019-08-06 Exercise | 2019-08-08 7:39 pm | N/A 2022-01-12 | NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer | 80,000 | $8.66 | 903,363 (Direct) | View |
| 2019-06-26 Option Award | 2019-06-27 7:39 pm | N/A 2029-06-25 | Xencor Inc | XNCR | GORMAN KEVIN CHARLES Director | 12,731 | $0 | 12,731 (Direct) | View |